-
1
-
-
0027480960
-
A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes
-
doi:10.1016/0092-8674(93)90585-E, the Huntington's Disease Collaborative Research Group
-
the Huntington's Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72: 971-983. doi:10.1016/0092-8674(93)90585-E. PubMed: 8458085.
-
(1993)
Cell
, vol.72
, pp. 971-983
-
-
-
2
-
-
84864749266
-
The incidence and prevalence of Huntington's disease: a systematic review and meta-analysis
-
doi:10.1002/mds.25075
-
Pringsheim T, Wiltshire K, Day L, Dykeman J, Steeves T, et al. (2012) The incidence and prevalence of Huntington's disease: a systematic review and meta-analysis. Mov Disord 27: 1083-1091. doi:10.1002/mds.25075. PubMed: 22692795.
-
(2012)
Mov Disord
, vol.27
, pp. 1083-1091
-
-
Pringsheim, T.1
Wiltshire, K.2
Day, L.3
Dykeman, J.4
Steeves, T.5
-
3
-
-
78650026297
-
Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis
-
doi:10.1016/S1474-4422(10)70276-3
-
Tabrizi SJ, Scahill RI, Durr A, Roos RA, Leavitt BR, et al. (2011) Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis. Lancet Neurol 10: 31-42. doi:10.1016/S1474-4422(10)70276-3. PubMed: 21130037.
-
(2011)
Lancet Neurol
, vol.10
, pp. 31-42
-
-
Tabrizi, S.J.1
Scahill, R.I.2
Durr, A.3
Roos, R.A.4
Leavitt, B.R.5
-
4
-
-
0027939105
-
Oxidative damage and mitochondrial dysfunction in neurodegenerative diseases
-
PubMed:7698395
-
Browne SE, Beal MF, (1994) Oxidative damage and mitochondrial dysfunction in neurodegenerative diseases. Biochem Soc Trans 22: 1002-1006. PubMed: 7698395.
-
(1994)
Biochem Soc Trans
, vol.22
, pp. 1002-1006
-
-
Browne, S.E.1
Beal, M.F.2
-
5
-
-
33749042331
-
Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration
-
doi:10.1016/j.cell.2006.09.015
-
Cui L, Jeong H, Borovecki F, Parkhurst CN, Tanese N, et al. (2006) Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration. Cell 127: 59-69. doi:10.1016/j.cell.2006.09.015. PubMed: 17018277.
-
(2006)
Cell
, vol.127
, pp. 59-69
-
-
Cui, L.1
Jeong, H.2
Borovecki, F.3
Parkhurst, C.N.4
Tanese, N.5
-
6
-
-
0036327065
-
Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines
-
PubMed:12089530
-
Panov AV, Gutekunst CA, Leavitt BR, Hayden MR, Burke JR, et al. (2002) Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines. Nat Neurosci 5: 731-736. PubMed: 12089530.
-
(2002)
Nat Neurosci
, vol.5
, pp. 731-736
-
-
Panov, A.V.1
Gutekunst, C.A.2
Leavitt, B.R.3
Hayden, M.R.4
Burke, J.R.5
-
7
-
-
0035937523
-
Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity
-
doi:10.1126/science.1056784
-
Nucifora FC Jr., Sasaki M, Peters MF, Huang H, Cooper JK, et al. (2001) Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity. Science 291: 2423-2428. doi:10.1126/science.1056784. PubMed: 11264541.
-
(2001)
Science
, vol.291
, pp. 2423-2428
-
-
Nucifora Jr., F.C.1
Sasaki, M.2
Peters, M.F.3
Huang, H.4
Cooper, J.K.5
-
8
-
-
0037150687
-
Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease
-
doi:10.1126/science.1072613
-
Dunah AW, Jeong H, Griffin A, Kim YM, Standaert DG, et al. (2002) Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease. Science 296: 2238-2243. doi:10.1126/science.1072613. PubMed: 11988536.
-
(2002)
Science
, vol.296
, pp. 2238-2243
-
-
Dunah, A.W.1
Jeong, H.2
Griffin, A.3
Kim, Y.M.4
Standaert, D.G.5
-
9
-
-
4444316194
-
Mutant huntingtin impairs axonal trafficking in mammalian neurons in vivo and in vitro
-
doi:10.1128/MCB.24.18.8195-8209.2004
-
Trushina E, Dyer RB, Badger JD 2nd, Ure D, Eide L, et al. (2004) Mutant huntingtin impairs axonal trafficking in mammalian neurons in vivo and in vitro. Mol Cell Biol 24: 8195-8209. doi:10.1128/MCB.24.18.8195-8209.2004. PubMed: 15340079.
-
(2004)
Mol Cell Biol
, vol.24
, pp. 8195-8209
-
-
Trushina, E.1
Dyer, R.B.2
Badger 2nd, J.D.3
Ure, D.4
Eide, L.5
-
10
-
-
84863806222
-
Alterations in Brain Transition Metals in Huntington Disease: An Evolving and Intricate Story
-
PubMed:22393169
-
Rosas HD, Chen YI, Doros G, Salat DH, Chen NK, et al. (2012) Alterations in Brain Transition Metals in Huntington Disease: An Evolving and Intricate Story. Arch Neurol: Epub. PubMed: 22393169.
-
(2012)
Arch Neurol
-
-
Rosas, H.D.1
Chen, Y.I.2
Doros, G.3
Salat, D.H.4
Chen, N.K.5
-
11
-
-
0025821265
-
Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia
-
doi:10.1093/brain/114.4.1953
-
Dexter DT, Carayon A, Javoy-Agid F, Agid Y, Wells FR, et al. (1991) Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia. Brain 114(4):: 1953-1975. doi:10.1093/brain/114.4.1953. PubMed: 1832073.
-
(1991)
Brain
, vol.114
, pp. 1953-1975
-
-
Dexter, D.T.1
Carayon, A.2
Javoy-Agid, F.3
Agid, Y.4
Wells, F.R.5
-
12
-
-
64049096553
-
Fenton chemistry and oxidative stress mediate the toxicity of the beta-amyloid peptide in a Drosophila model of Alzheimer's disease
-
doi:10.1111/j.1460-9568.2009.06701.x
-
Rival T, Page RM, Chandraratna DS, Sendall TJ, Ryder E, et al. (2009) Fenton chemistry and oxidative stress mediate the toxicity of the beta-amyloid peptide in a Drosophila model of Alzheimer's disease. Eur J Neurosci 29: 1335-1347. doi:10.1111/j.1460-9568.2009.06701.x. PubMed: 19519625.
-
(2009)
Eur J Neurosci
, vol.29
, pp. 1335-1347
-
-
Rival, T.1
Page, R.M.2
Chandraratna, D.S.3
Sendall, T.J.4
Ryder, E.5
-
13
-
-
0242684415
-
Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson's disease
-
doi:10.1016/S0896-6273(03)00126-0
-
Kaur D, Yantiri F, Rajagopalan S, Kumar J, Mo JQ, et al. (2003) Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson's disease. Neuron 37: 899-909. doi:10.1016/S0896-6273(03)00126-0. PubMed: 12670420.
-
(2003)
Neuron
, vol.37
, pp. 899-909
-
-
Kaur, D.1
Yantiri, F.2
Rajagopalan, S.3
Kumar, J.4
Mo, J.Q.5
-
14
-
-
67349106731
-
A novel transferrin/TfR2-mediated mitochondrial iron transport system is disrupted in Parkinson's disease
-
doi:10.1016/j.nbd.2009.02.009
-
Mastroberardino PG, Hoffman EK, Horowitz MP, Betarbet R, Taylor G, et al. (2009) A novel transferrin/TfR2-mediated mitochondrial iron transport system is disrupted in Parkinson's disease. Neurobiol Dis 34: 417-431. doi:10.1016/j.nbd.2009.02.009. PubMed: 19250966.
-
(2009)
Neurobiol Dis
, vol.34
, pp. 417-431
-
-
Mastroberardino, P.G.1
Hoffman, E.K.2
Horowitz, M.P.3
Betarbet, R.4
Taylor, G.5
-
15
-
-
58849116869
-
Dysregulation of iron homeostasis in the CNS contributes to disease progression in a mouse model of amyotrophic lateral sclerosis
-
doi:10.1523/JNEUROSCI.5443-08.2009
-
Jeong SY, Rathore KI, Schulz K, Ponka P, Arosio P, et al. (2009) Dysregulation of iron homeostasis in the CNS contributes to disease progression in a mouse model of amyotrophic lateral sclerosis. J Neurosci 29: 610-619. doi:10.1523/JNEUROSCI.5443-08.2009. PubMed: 19158288.
-
(2009)
J Neurosci
, vol.29
, pp. 610-619
-
-
Jeong, S.Y.1
Rathore, K.I.2
Schulz, K.3
Ponka, P.4
Arosio, P.5
-
16
-
-
63449135100
-
Abnormal brain iron homeostasis in human and animal prion disorders
-
PubMed:19283067
-
Singh A, Isaac AO, Luo X, Mohan ML, Cohen ML, et al. (2009) Abnormal brain iron homeostasis in human and animal prion disorders. PLOS Pathog 5: e1000336. PubMed: 19283067.
-
(2009)
PLOS Pathog
, vol.5
-
-
Singh, A.1
Isaac, A.O.2
Luo, X.3
Mohan, M.L.4
Cohen, M.L.5
-
17
-
-
0034941118
-
Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease
-
doi:10.1038/ng571
-
Curtis AR, Fey C, Morris CM, Bindoff LA, Ince PG, et al. (2001) Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease. Nat Genet 28: 350-354. doi:10.1038/ng571. PubMed: 11438811.
-
(2001)
Nat Genet
, vol.28
, pp. 350-354
-
-
Curtis, A.R.1
Fey, C.2
Morris, C.M.3
Bindoff, L.A.4
Ince, P.G.5
-
18
-
-
0346847502
-
Aceruloplasminemia, an iron metabolic disorder
-
doi:10.1046/j.1440-1789.2003.00521.x
-
Miyajima H, (2003) Aceruloplasminemia, an iron metabolic disorder. Neuropathology 23: 345-350. doi:10.1046/j.1440-1789.2003.00521.x. PubMed: 14719552.
-
(2003)
Neuropathology
, vol.23
, pp. 345-350
-
-
Miyajima, H.1
-
19
-
-
34548406422
-
Huntingtin-deficient zebrafish exhibit defects in iron utilization and development
-
doi:10.1093/hmg/ddm138
-
Lumsden AL, Henshall TL, Dayan S, Lardelli MT, Richards RI, (2007) Huntingtin-deficient zebrafish exhibit defects in iron utilization and development. Hum Mol Genet 16: 1905-1920. doi:10.1093/hmg/ddm138. PubMed: 17567778.
-
(2007)
Hum Mol Genet
, vol.16
, pp. 1905-1920
-
-
Lumsden, A.L.1
Henshall, T.L.2
Dayan, S.3
Lardelli, M.T.4
Richards, R.I.5
-
20
-
-
55349106939
-
Mechanisms of copper ion mediated Huntington's disease progression
-
doi:10.1371/journal.pone.0000334
-
Fox JH, Kama JA, Lieberman G, Chopra R, Dorsey K, et al. (2007) Mechanisms of copper ion mediated Huntington's disease progression. PLOS ONE 2: e334. doi:10.1371/journal.pone.0000334. PubMed: 17396163.
-
(2007)
PLOS ONE
, vol.2
-
-
Fox, J.H.1
Kama, J.A.2
Lieberman, G.3
Chopra, R.4
Dorsey, K.5
-
21
-
-
84856708923
-
Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export
-
PubMed:22286308
-
Lei P, Ayton S, Finkelstein DI, Spoerri L, Ciccotosto GD, et al. (2011) Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export. Nat Med 18: 291-295. PubMed: 22286308.
-
(2011)
Nat Med
, vol.18
, pp. 291-295
-
-
Lei, P.1
Ayton, S.2
Finkelstein, D.I.3
Spoerri, L.4
Ciccotosto, G.D.5
-
22
-
-
77956647381
-
Iron-export ferroxidase activity of beta-amyloid precursor protein is inhibited by zinc in Alzheimer's disease
-
doi:10.1016/j.cell.2010.08.014
-
Duce JA, Tsatsanis A, Cater MA, James SA, Robb E, et al. (2010) Iron-export ferroxidase activity of beta-amyloid precursor protein is inhibited by zinc in Alzheimer's disease. Cell 142: 857-867. doi:10.1016/j.cell.2010.08.014. PubMed: 20817278.
-
(2010)
Cell
, vol.142
, pp. 857-867
-
-
Duce, J.A.1
Tsatsanis, A.2
Cater, M.A.3
James, S.A.4
Robb, E.5
-
23
-
-
79251572323
-
Alpha-synuclein is a cellular ferrireductase
-
doi:10.1371/journal.pone.0015814
-
Davies P, Moualla D, Brown DR, (2011) Alpha-synuclein is a cellular ferrireductase. PLOS ONE 6: e15814. doi:10.1371/journal.pone.0015814. PubMed: 21249223.
-
(2011)
PLOS ONE
, vol.6
-
-
Davies, P.1
Moualla, D.2
Brown, D.R.3
-
24
-
-
84862953172
-
Amyloid precursor protein revisited: neuron-specific expression and highly stable nature of soluble derivatives
-
doi:10.1074/jbc.M111.315051
-
Guo Q, Li H, Gaddam SS, Justice NJ, Robertson CS, et al. (2012) Amyloid precursor protein revisited: neuron-specific expression and highly stable nature of soluble derivatives. J Biol Chem 287: 2437-2445. doi:10.1074/jbc.M111.315051. PubMed: 22144675.
-
(2012)
J Biol Chem
, vol.287
, pp. 2437-2445
-
-
Guo, Q.1
Li, H.2
Gaddam, S.S.3
Justice, N.J.4
Robertson, C.S.5
-
25
-
-
84878398613
-
Ceruloplasmin dysfunction and therapeutic potential for parkinson disease
-
PubMed: 23424051
-
Ayton S, Lei P, Duce JA, Wong BX, Sedjahtera A, et al. (2013) Ceruloplasmin dysfunction and therapeutic potential for parkinson disease. Ann Neurol. PubMed: 23424051.
-
(2013)
Ann Neurol
-
-
Ayton, S.1
Lei, P.2
Duce, J.A.3
Wong, B.X.4
Sedjahtera, A.5
-
26
-
-
20444416123
-
The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis
-
doi:10.1016/j.cmet.2005.01.003
-
Donovan A, Lima CA, Pinkus JL, Pinkus GS, Zon LI, et al. (2005) The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis. Cell Metab 1: 191-200. doi:10.1016/j.cmet.2005.01.003. PubMed: 16054062.
-
(2005)
Cell Metab
, vol.1
, pp. 191-200
-
-
Donovan, A.1
Lima, C.A.2
Pinkus, J.L.3
Pinkus, G.S.4
Zon, L.I.5
-
27
-
-
16044373842
-
Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice
-
doi:10.1016/S0092-8674(00)81369-0
-
Mangiarini L, Sathasivam K, Seller M, Cozens B, Harper A, et al. (1996) Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87: 493-506. doi:10.1016/S0092-8674(00)81369-0. PubMed: 8898202.
-
(1996)
Cell
, vol.87
, pp. 493-506
-
-
Mangiarini, L.1
Sathasivam, K.2
Seller, M.3
Cozens, B.4
Harper, A.5
-
28
-
-
43649106471
-
Sertraline slows disease progression and increases neurogenesis in N171-82Q mouse model of Huntington's disease
-
doi:10.1016/j.nbd.2008.01.015
-
Duan W, Peng Q, Masuda N, Ford E, Tryggestad E, et al. (2008) Sertraline slows disease progression and increases neurogenesis in N171-82Q mouse model of Huntington's disease. Neurobiol Dis 30: 312-322. doi:10.1016/j.nbd.2008.01.015. PubMed: 18403212.
-
(2008)
Neurobiol Dis
, vol.30
, pp. 312-322
-
-
Duan, W.1
Peng, Q.2
Masuda, N.3
Ford, E.4
Tryggestad, E.5
-
29
-
-
77953665285
-
The mTOR kinase inhibitor Everolimus decreases S6 kinase phosphorylation but fails to reduce mutant huntingtin levels in brain and is not neuroprotective in the R6/2 mouse model of Huntington's disease
-
doi:10.1186/1750-1326-5-26
-
Fox JH, Connor T, Chopra V, Dorsey K, Kama JA, et al. (2010) The mTOR kinase inhibitor Everolimus decreases S6 kinase phosphorylation but fails to reduce mutant huntingtin levels in brain and is not neuroprotective in the R6/2 mouse model of Huntington's disease. Mol Neurodegener 5: 26. doi:10.1186/1750-1326-5-26. PubMed: 20569486.
-
(2010)
Mol Neurodegener
, vol.5
, pp. 26
-
-
Fox, J.H.1
Connor, T.2
Chopra, V.3
Dorsey, K.4
Kama, J.A.5
-
30
-
-
33646145729
-
Gender and genetic background effects on brain metal levels in APP transgenic and normal mice: implications for Alzheimer beta-amyloid pathology
-
doi:10.1016/j.jinorgbio.2006.02.010
-
Maynard CJ, Cappai R, Volitakis I, Cherny RA, Masters CL, et al. (2006) Gender and genetic background effects on brain metal levels in APP transgenic and normal mice: implications for Alzheimer beta-amyloid pathology. J Inorg Biochem 100: 952-962. doi:10.1016/j.jinorgbio.2006.02.010. PubMed: 16574231.
-
(2006)
J Inorg Biochem
, vol.100
, pp. 952-962
-
-
Maynard, C.J.1
Cappai, R.2
Volitakis, I.3
Cherny, R.A.4
Masters, C.L.5
-
31
-
-
2442445100
-
High-throughput non-heme iron assay for animal tissues
-
doi:10.1016/j.jbbm.2004.01.001
-
Grundy MA, Gorman N, Sinclair PR, Chorney MJ, Gerhard GS, (2004) High-throughput non-heme iron assay for animal tissues. J Biochem Biophys Methods 59: 195-200. doi:10.1016/j.jbbm.2004.01.001. PubMed: 15163531.
-
(2004)
J Biochem Biophys Methods
, vol.59
, pp. 195-200
-
-
Grundy, M.A.1
Gorman, N.2
Sinclair, P.R.3
Chorney, M.J.4
Gerhard, G.S.5
-
32
-
-
65549099134
-
Cellular and subcellular localizations of nonheme ferric and ferrous iron in the rat brain: a light and electron microscopic study by the perfusion-Perls and -Turnbull methods
-
doi:10.1679/aohc.71.205
-
Meguro R, Asano Y, Odagiri S, Li C, Shoumura K, (2008) Cellular and subcellular localizations of nonheme ferric and ferrous iron in the rat brain: a light and electron microscopic study by the perfusion-Perls and-Turnbull methods. Arch Histol Cytol 71: 205-222. doi:10.1679/aohc.71.205. PubMed: 19359804.
-
(2008)
Arch Histol Cytol
, vol.71
, pp. 205-222
-
-
Meguro, R.1
Asano, Y.2
Odagiri, S.3
Li, C.4
Shoumura, K.5
-
33
-
-
84857828366
-
Caenorhabditis elegans maintains highly compartmentalized cellular distribution of metals and steep concentration gradients of manganese
-
doi:10.1371/journal.pone.0032685
-
McColl G, James SA, Mayo S, Howard DL, Ryan CG, et al. (2012) Caenorhabditis elegans maintains highly compartmentalized cellular distribution of metals and steep concentration gradients of manganese. PLOS ONE 7: e32685. doi:10.1371/journal.pone.0032685. PubMed: 22393436.
-
(2012)
PLOS ONE
, vol.7
-
-
McColl, G.1
James, S.A.2
Mayo, S.3
Howard, D.L.4
Ryan, C.G.5
-
35
-
-
0027452550
-
Regulating the fate of mRNA: the control of cellular iron metabolism
-
doi:10.1016/0092-8674(93)90046-S
-
Klausner RD, Rouault TA, Harford JB, (1993) Regulating the fate of mRNA: the control of cellular iron metabolism. Cell 72: 19-28. doi:10.1016/0092-8674(93)90046-S. PubMed: 8380757.
-
(1993)
Cell
, vol.72
, pp. 19-28
-
-
Klausner, R.D.1
Rouault, T.A.2
Harford, J.B.3
-
36
-
-
33745205646
-
Intralysosomal iron chelation protects against oxidative stress-induced cellular damage
-
doi:10.1111/j.1742-4658.2006.05321.x
-
Kurz T, Gustafsson B, Brunk UT, (2006) Intralysosomal iron chelation protects against oxidative stress-induced cellular damage. FEBS J 273: 3106-3117. doi:10.1111/j.1742-4658.2006.05321.x. PubMed: 16762036.
-
(2006)
FEBS J
, vol.273
, pp. 3106-3117
-
-
Kurz, T.1
Gustafsson, B.2
Brunk, U.T.3
-
37
-
-
39749110624
-
Oxidative stress and iron homeostasis: mechanistic and health aspects
-
doi:10.1080/10408360701713104
-
Galaris D, Pantopoulos K, (2008) Oxidative stress and iron homeostasis: mechanistic and health aspects. Crit Rev Clin Lab Sci 45: 1-23. doi:10.1080/10408360701713104. PubMed: 18293179.
-
(2008)
Crit Rev Clin Lab Sci
, vol.45
, pp. 1-23
-
-
Galaris, D.1
Pantopoulos, K.2
-
38
-
-
59449107434
-
Multiple protective activities of neuroglobin in cultured neuronal cells exposed to hypoxia re-oxygenation injury
-
doi:10.1111/j.1471-4159.2008.05846.x
-
Duong TT, Witting PK, Antao ST, Parry SN, Kennerson M, et al. (2009) Multiple protective activities of neuroglobin in cultured neuronal cells exposed to hypoxia re-oxygenation injury. J Neurochem 108: 1143-1154. doi:10.1111/j.1471-4159.2008.05846.x. PubMed: 19154338.
-
(2009)
J Neurochem
, vol.108
, pp. 1143-1154
-
-
Duong, T.T.1
Witting, P.K.2
Antao, S.T.3
Parry, S.N.4
Kennerson, M.5
-
39
-
-
33751561930
-
X-ray fluorescence microprobe imaging in biology and medicine
-
doi:10.1002/jcb.21047
-
Paunesku T, Vogt S, Maser J, Lai B, Woloschak G, (2006) X-ray fluorescence microprobe imaging in biology and medicine. J Cell Biochem 99: 1489-1502. doi:10.1002/jcb.21047. PubMed: 17006954.
-
(2006)
J Cell Biochem
, vol.99
, pp. 1489-1502
-
-
Paunesku, T.1
Vogt, S.2
Maser, J.3
Lai, B.4
Woloschak, G.5
-
40
-
-
84889356535
-
Ultrastructural Pathology: The Comparative Cellular Basis of Disease
-
Cheville NF, (2009) Ultrastructural Pathology: The Comparative Cellular Basis of Disease. Wiley-Blackwell. pp. 1000 pp.
-
(2009)
Wiley-Blackwell
, pp. 1000
-
-
Cheville, N.F.1
-
41
-
-
2642586352
-
Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease
-
doi:10.1038/ng1362
-
Ravikumar B, Vacher C, Berger Z, Davies JE, Luo S, et al. (2004) Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat Genet 36: 585-595. doi:10.1038/ng1362. PubMed: 15146184.
-
(2004)
Nat Genet
, vol.36
, pp. 585-595
-
-
Ravikumar, B.1
Vacher, C.2
Berger, Z.3
Davies, J.E.4
Luo, S.5
-
42
-
-
18544410106
-
Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation
-
doi:10.1016/S0092-8674(00)80513-9
-
Davies SW, Turmaine M, Cozens BA, DiFiglia M, Sharp AH, et al. (1997) Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 90: 537-548. doi:10.1016/S0092-8674(00)80513-9. PubMed: 9267033.
-
(1997)
Cell
, vol.90
, pp. 537-548
-
-
Davies, S.W.1
Turmaine, M.2
Cozens, B.A.3
DiFiglia, M.4
Sharp, A.H.5
-
43
-
-
34447520021
-
Ferritin accumulation in dystrophic microglia is an early event in the development of Huntington's disease
-
doi:10.1002/glia.20526
-
Simmons DA, Casale M, Alcon B, Pham N, Narayan N, et al. (2007) Ferritin accumulation in dystrophic microglia is an early event in the development of Huntington's disease. Glia 55: 1074-1084. doi:10.1002/glia.20526. PubMed: 17551926.
-
(2007)
Glia
, vol.55
, pp. 1074-1084
-
-
Simmons, D.A.1
Casale, M.2
Alcon, B.3
Pham, N.4
Narayan, N.5
-
44
-
-
0031837533
-
Huntington disease
-
doi:10.1097/00005072-199805000-00001
-
Vonsattel JP, DiFiglia M, (1998) Huntington disease. J Neuropathol Exp Neurol 57: 369-384. doi:10.1097/00005072-199805000-00001. PubMed: 9596408.
-
(1998)
J Neuropathol Exp Neurol
, vol.57
, pp. 369-384
-
-
Vonsattel, J.P.1
DiFiglia, M.2
-
45
-
-
36749022180
-
A small-molecule therapeutic lead for Huntington's disease: preclinical pharmacology and efficacy of C2-8 in the R6/2 transgenic mouse
-
doi:10.1073/pnas.0707842104
-
Chopra V, Fox JH, Lieberman G, Dorsey K, Matson W, et al. (2007) A small-molecule therapeutic lead for Huntington's disease: preclinical pharmacology and efficacy of C2-8 in the R6/2 transgenic mouse. Proc Natl Acad Sci U S A 104: 16685-16689. doi:10.1073/pnas.0707842104. PubMed: 17925440.
-
(2007)
Proc Natl Acad Sci U S A
, vol.104
, pp. 16685-16689
-
-
Chopra, V.1
Fox, J.H.2
Lieberman, G.3
Dorsey, K.4
Matson, W.5
-
46
-
-
0034608857
-
Nonapoptotic neurodegeneration in a transgenic mouse model of Huntington's disease
-
doi:10.1073/pnas.110078997
-
Turmaine M, Raza A, Mahal A, Mangiarini L, Bates GP, et al. (2000) Nonapoptotic neurodegeneration in a transgenic mouse model of Huntington's disease. Proc Natl Acad Sci U S A 97: 8093-8097. doi:10.1073/pnas.110078997. PubMed: 10869421.
-
(2000)
Proc Natl Acad Sci U S A
, vol.97
, pp. 8093-8097
-
-
Turmaine, M.1
Raza, A.2
Mahal, A.3
Mangiarini, L.4
Bates, G.P.5
-
47
-
-
84863992162
-
Accumulating microglia phagocytose injured neurons in hippocampal slice cultures: involvement of p38 MAP kinase
-
doi:10.1371/journal.pone.0040813
-
Katayama T, Kobayashi H, Okamura T, Yamasaki-Katayama Y, Kibayashi T, et al. (2012) Accumulating microglia phagocytose injured neurons in hippocampal slice cultures: involvement of p38 MAP kinase. PLOS ONE 7: e40813. doi:10.1371/journal.pone.0040813. PubMed: 22815830.
-
(2012)
PLOS ONE
, vol.7
-
-
Katayama, T.1
Kobayashi, H.2
Okamura, T.3
Yamasaki-Katayama, Y.4
Kibayashi, T.5
-
48
-
-
84862334971
-
Primary phagocytosis of neurons by inflamed microglia: potential roles in neurodegeneration
-
Neher JJ, Neniskyte U, Brown GC, (2012) Primary phagocytosis of neurons by inflamed microglia: potential roles in neurodegeneration. Front. Pharmacologist 3: 27.
-
(2012)
Front. Pharmacologist
, vol.3
, pp. 27
-
-
Neher, J.J.1
Neniskyte, U.2
Brown, G.C.3
-
49
-
-
84858078783
-
Iron homeostasis in astrocytes and microglia is differentially regulated by TNF-alpha and TGF-beta1
-
doi:10.1002/glia.22303
-
Rathore KI, Redensek A, David S, (2012) Iron homeostasis in astrocytes and microglia is differentially regulated by TNF-alpha and TGF-beta1. Glia 60: 738-750. doi:10.1002/glia.22303. PubMed: 22298416.
-
(2012)
Glia
, vol.60
, pp. 738-750
-
-
Rathore, K.I.1
Redensek, A.2
David, S.3
-
50
-
-
84864319642
-
Mammalian iron metabolism and its control by iron regulatory proteins
-
doi:10.1016/j.bbamcr.2012.05.010
-
Anderson CP, Shen M, Eisenstein RS, Leibold EA, (2012) Mammalian iron metabolism and its control by iron regulatory proteins. Biochim Biophys Acta 1823: 1468-1483. doi:10.1016/j.bbamcr.2012.05.010. PubMed: 22610083.
-
(2012)
Biochim Biophys Acta
, vol.1823
, pp. 1468-1483
-
-
Anderson, C.P.1
Shen, M.2
Eisenstein, R.S.3
Leibold, E.A.4
-
51
-
-
0034703869
-
Dominant phenotypes produced by the HD mutation in STHdh(Q111) striatal cells
-
doi:10.1093/hmg/9.19.2799
-
Trettel F, Rigamonti D, Hilditch-Maguire P, Wheeler VC, Sharp AH, et al. (2000) Dominant phenotypes produced by the HD mutation in STHdh(Q111) striatal cells. Hum Mol Genet 9: 2799-2809. doi:10.1093/hmg/9.19.2799. PubMed: 11092756.
-
(2000)
Hum Mol Genet
, vol.9
, pp. 2799-2809
-
-
Trettel, F.1
Rigamonti, D.2
Hilditch-Maguire, P.3
Wheeler, V.C.4
Sharp, A.H.5
-
52
-
-
0347928847
-
An iron-responsive element type II in the 5'-untranslated region of the Alzheimer's amyloid precursor protein transcript
-
doi:10.1074/jbc.M207435200
-
Rogers JT, Randall JD, Cahill CM, Eder PS, Huang X, et al. (2002) An iron-responsive element type II in the 5'-untranslated region of the Alzheimer's amyloid precursor protein transcript. J Biol Chem 277: 45518-45528. doi:10.1074/jbc.M207435200. PubMed: 12198135.
-
(2002)
J Biol Chem
, vol.277
, pp. 45518-45528
-
-
Rogers, J.T.1
Randall, J.D.2
Cahill, C.M.3
Eder, P.S.4
Huang, X.5
-
54
-
-
33751080354
-
Huntingtin inclusion bodies are iron-dependent centers of oxidative events
-
doi:10.1111/j.1742-4658.2006.05537.x
-
Firdaus WJ, Wyttenbach A, Giuliano P, Kretz-Remy C, Currie RW, et al. (2006) Huntingtin inclusion bodies are iron-dependent centers of oxidative events. FEBS J 273: 5428-5441. doi:10.1111/j.1742-4658.2006.05537.x. PubMed: 17116244.
-
(2006)
FEBS J
, vol.273
, pp. 5428-5441
-
-
Firdaus, W.J.1
Wyttenbach, A.2
Giuliano, P.3
Kretz-Remy, C.4
Currie, R.W.5
-
55
-
-
23844482456
-
Clioquinol down-regulates mutant huntingtin expression in vitro and mitigates pathology in a Huntington's disease mouse model
-
doi:10.1073/pnas.0502177102
-
Nguyen T, Hamby A, Massa SM, (2005) Clioquinol down-regulates mutant huntingtin expression in vitro and mitigates pathology in a Huntington's disease mouse model. Proc Natl Acad Sci U S A 102: 11840-11845. doi:10.1073/pnas.0502177102. PubMed: 16087879.
-
(2005)
Proc Natl Acad Sci U S A
, vol.102
, pp. 11840-11845
-
-
Nguyen, T.1
Hamby, A.2
Massa, S.M.3
-
56
-
-
84885372632
-
PBT2 reduces toxicity in a C.elegans model of polyQ aggregation and extends lifespan, reduces striatal atrophy and improves motor performance in the R6/2 mouse model of Huntington's disease
-
Cherny RA, Ayton S, Finkelstein DI, Bush AI, McColl G, et al. (2012) PBT2 reduces toxicity in a C.elegans model of polyQ aggregation and extends lifespan, reduces striatal atrophy and improves motor performance in the R6/2 mouse model of Huntington's disease. J Huntington's Dis 1: 211-219.
-
(2012)
J Huntington's Dis
, vol.1
, pp. 211-219
-
-
Cherny, R.A.1
Ayton, S.2
Finkelstein, D.I.3
Bush, A.I.4
McColl, G.5
-
57
-
-
84856707768
-
Different 8-hydroxyquinolines protect models of TDP-43 protein, alpha-synuclein, and polyglutamine proteotoxicity through distinct mechanisms
-
doi:10.1074/jbc.M111.308668
-
Tardiff DF, Tucci ML, Caldwell KA, Caldwell GA, Lindquist S, (2012) Different 8-hydroxyquinolines protect models of TDP-43 protein, alpha-synuclein, and polyglutamine proteotoxicity through distinct mechanisms. J Biol Chem 287: 4107-4120. doi:10.1074/jbc.M111.308668. PubMed: 22147697.
-
(2012)
J Biol Chem
, vol.287
, pp. 4107-4120
-
-
Tardiff, D.F.1
Tucci, M.L.2
Caldwell, K.A.3
Caldwell, G.A.4
Lindquist, S.5
-
58
-
-
84861184989
-
Elevated brain iron is independent from atrophy in Huntington's Disease
-
doi:10.1016/j.neuroimage.2012.03.056
-
Dumas EM, Versluis MJ, van den Bogaard SJ, van Osch MJ, Hart EP, et al. (2012) Elevated brain iron is independent from atrophy in Huntington's Disease. NeuroImage 61: 558-564. doi:10.1016/j.neuroimage.2012.03.056. PubMed: 22480728.
-
(2012)
NeuroImage
, vol.61
, pp. 558-564
-
-
Dumas, E.M.1
Versluis, M.J.2
van den Bogaard, S.J.3
van Osch, M.J.4
Hart, E.P.5
-
59
-
-
13944261999
-
Imaging iron stores in the brain using magnetic resonance imaging
-
doi:10.1016/j.mri.2004.10.001
-
Haacke EM, Cheng NY, House MJ, Liu Q, Neelavalli J, et al. (2005) Imaging iron stores in the brain using magnetic resonance imaging. Magn Reson Imaging 23: 1-25. doi:10.1016/j.mri.2004.10.001. PubMed: 15733784.
-
(2005)
Magn Reson Imaging
, vol.23
, pp. 1-25
-
-
Haacke, E.M.1
Cheng, N.Y.2
House, M.J.3
Liu, Q.4
Neelavalli, J.5
|